| 1 | sustained | 7,813 |
| 2 | unsustained | 36 |
| 3 | fear-potentiated | 18 |
| 4 | stimulus-driven | 15 |
| 5 | global/clinical | 10 |
| 6 | cvw | 9 |
| 7 | emotion-potentiated | 8 |
| 8 | water-assisted | 7 |
| 9 | ccyr/met- | 6 |
| 10 | eye-blink | 6 |
| 11 | ph-modified | 5 |
| 12 | rotaflow | 5 |
| 13 | trauma-potentiated | 5 |
| 14 | anxiety-potentiated | 4 |
| 15 | hypoxia-dependent | 4 |
| 16 | post-transition | 4 |
| 17 | pseudo-steady-state | 4 |
| 18 | stimulation-related | 4 |
| 19 | treatment-mediated | 4 |
| 20 | co-validated | 3 |
| 21 | jendeki | 3 |
| 22 | mbl-associated | 3 |
| 23 | micro-metastasis | 3 |
| 24 | nac-induced | 3 |
| 25 | trans-septum | 3 |
| 26 | ≥3-step | 3 |
| 27 | 2.3-log | 2 |
| 28 | 28-defined | 2 |
| 29 | art-mediated | 2 |
| 30 | bioverified | 2 |
| 31 | cortisol-related | 2 |
| 32 | generic-generic | 2 |
| 33 | hydrazine/hydroxylamine-assisted | 2 |
| 34 | legumain-like | 2 |
| 35 | longer-latency | 2 |
| 36 | nonsynchronous | 2 |
| 37 | ns3/ns4a | 2 |
| 38 | study-induced | 2 |
| 39 | tclpb | 2 |
| 40 | 1.5-mev | 1 |
| 41 | 10-12rm | 1 |
| 42 | 2.07-fold | 1 |
| 43 | 25.5-26.5°c | 1 |
| 44 | 3.38-log | 1 |
| 45 | 4.8-log | 1 |
| 46 | 5-hydroxytryptophan-induced | 1 |
| 47 | 87.5-log | 1 |
| 48 | 9-mg/dl | 1 |
| 49 | 9delta | 1 |
| 50 | absence-seizures | 1 |
| 51 | activity/protein | 1 |
| 52 | alvimopan-induced | 1 |
| 53 | amrinone-induced | 1 |
| 54 | arms2/htra | 1 |
| 55 | aza-peptidyl | 1 |
| 56 | boltzmann-weighted | 1 |
| 57 | burst-sustained | 1 |
| 58 | carbon-4 | 1 |
| 59 | cyclosis-mediated | 1 |
| 60 | cyclotron-based | 1 |
| 61 | deprotection/thiol-acrylate | 1 |
| 62 | doi-induced | 1 |
| 63 | elastase-related | 1 |
| 64 | es=0.43 | 1 |
| 65 | g-imino | 1 |
| 66 | glycosylphosphatidylinositol-linked | 1 |
| 67 | herpesvirus-associated | 1 |
| 68 | hydrazinic | 1 |
| 69 | immunofixation-negative | 1 |
| 70 | ketamine-evoked | 1 |
| 71 | mass-screenings | 1 |
| 72 | mbl/ficolin/collectin-11-associated | 1 |
| 73 | microcon | 1 |
| 74 | minor-to-moderate | 1 |
| 75 | motivationally-enhanced | 1 |
| 76 | non-concentration-dependent | 1 |
| 77 | nonhabituating | 1 |
| 78 | ph-metry-adjusted | 1 |
| 79 | phosphotidyl | 1 |
| 80 | pps-guided | 1 |
| 81 | proteasome-glo | 1 |
| 82 | pulsatile-controlled | 1 |
| 83 | reinforcement-controlled | 1 |
| 84 | reversaling | 1 |
| 85 | s-nitrosocysteine | 1 |
| 86 | thirsty-six | 1 |
| 87 | transthylakoid | 1 |
| 88 | tricostatus | 1 |
| 89 | trypsin-nor | 1 |
| 90 | ventilatory-related | 1 |
| 91 | virus/serum | 1 |
| 92 | yet-to-be-identified | 1 |
| 1 | 1.5-mev | 1 |
| 2 | 10-12rm | 1 |
| 3 | 2.07-fold | 1 |
| 4 | 2.3-log | 2 |
| 5 | 25.5-26.5°c | 1 |
| 6 | 28-defined | 2 |
| 7 | 3.38-log | 1 |
| 8 | 4.8-log | 1 |
| 9 | 5-hydroxytryptophan-induced | 1 |
| 10 | 87.5-log | 1 |
| 11 | 9-mg/dl | 1 |
| 12 | 9delta | 1 |
| 13 | absence-seizures | 1 |
| 14 | activity/protein | 1 |
| 15 | alvimopan-induced | 1 |
| 16 | amrinone-induced | 1 |
| 17 | anxiety-potentiated | 4 |
| 18 | arms2/htra | 1 |
| 19 | art-mediated | 2 |
| 20 | aza-peptidyl | 1 |
| 21 | bioverified | 2 |
| 22 | boltzmann-weighted | 1 |
| 23 | burst-sustained | 1 |
| 24 | carbon-4 | 1 |
| 25 | ccyr/met- | 6 |
| 26 | co-validated | 3 |
| 27 | cortisol-related | 2 |
| 28 | cvw | 9 |
| 29 | cyclosis-mediated | 1 |
| 30 | cyclotron-based | 1 |
| 31 | deprotection/thiol-acrylate | 1 |
| 32 | doi-induced | 1 |
| 33 | elastase-related | 1 |
| 34 | emotion-potentiated | 8 |
| 35 | es=0.43 | 1 |
| 36 | eye-blink | 6 |
| 37 | fear-potentiated | 18 |
| 38 | g-imino | 1 |
| 39 | generic-generic | 2 |
| 40 | global/clinical | 10 |
| 41 | glycosylphosphatidylinositol-linked | 1 |
| 42 | herpesvirus-associated | 1 |
| 43 | hydrazine/hydroxylamine-assisted | 2 |
| 44 | hydrazinic | 1 |
| 45 | hypoxia-dependent | 4 |
| 46 | immunofixation-negative | 1 |
| 47 | jendeki | 3 |
| 48 | ketamine-evoked | 1 |
| 49 | legumain-like | 2 |
| 50 | longer-latency | 2 |
| 51 | mass-screenings | 1 |
| 52 | mbl-associated | 3 |
| 53 | mbl/ficolin/collectin-11-associated | 1 |
| 54 | micro-metastasis | 3 |
| 55 | microcon | 1 |
| 56 | minor-to-moderate | 1 |
| 57 | motivationally-enhanced | 1 |
| 58 | nac-induced | 3 |
| 59 | non-concentration-dependent | 1 |
| 60 | nonhabituating | 1 |
| 61 | nonsynchronous | 2 |
| 62 | ns3/ns4a | 2 |
| 63 | ph-metry-adjusted | 1 |
| 64 | ph-modified | 5 |
| 65 | phosphotidyl | 1 |
| 66 | post-transition | 4 |
| 67 | pps-guided | 1 |
| 68 | proteasome-glo | 1 |
| 69 | pseudo-steady-state | 4 |
| 70 | pulsatile-controlled | 1 |
| 71 | reinforcement-controlled | 1 |
| 72 | reversaling | 1 |
| 73 | rotaflow | 5 |
| 74 | s-nitrosocysteine | 1 |
| 75 | stimulation-related | 4 |
| 76 | stimulus-driven | 15 |
| 77 | study-induced | 2 |
| 78 | sustained | 7,813 |
| 79 | tclpb | 2 |
| 80 | thirsty-six | 1 |
| 81 | trans-septum | 3 |
| 82 | transthylakoid | 1 |
| 83 | trauma-potentiated | 5 |
| 84 | treatment-mediated | 4 |
| 85 | tricostatus | 1 |
| 86 | trypsin-nor | 1 |
| 87 | unsustained | 36 |
| 88 | ventilatory-related | 1 |
| 89 | virus/serum | 1 |
| 90 | water-assisted | 7 |
| 91 | yet-to-be-identified | 1 |
| 92 | ≥3-step | 3 |
| 1 | ccyr/met- | 6 |
| 2 | es=0.43 | 1 |
| 3 | carbon-4 | 1 |
| 4 | ns3/ns4a | 2 |
| 5 | arms2/htra | 1 |
| 6 | 9delta | 1 |
| 7 | tclpb | 2 |
| 8 | hydrazinic | 1 |
| 9 | generic-generic | 2 |
| 10 | 25.5-26.5°c | 1 |
| 11 | motivationally-enhanced | 1 |
| 12 | nac-induced | 3 |
| 13 | amrinone-induced | 1 |
| 14 | doi-induced | 1 |
| 15 | 5-hydroxytryptophan-induced | 1 |
| 16 | alvimopan-induced | 1 |
| 17 | study-induced | 2 |
| 18 | pps-guided | 1 |
| 19 | ph-modified | 5 |
| 20 | bioverified | 2 |
| 21 | yet-to-be-identified | 1 |
| 22 | glycosylphosphatidylinositol-linked | 1 |
| 23 | ketamine-evoked | 1 |
| 24 | pulsatile-controlled | 1 |
| 25 | reinforcement-controlled | 1 |
| 26 | sustained | 7,813 |
| 27 | burst-sustained | 1 |
| 28 | unsustained | 36 |
| 29 | 28-defined | 2 |
| 30 | cyclotron-based | 1 |
| 31 | co-validated | 3 |
| 32 | mbl/ficolin/collectin-11-associated | 1 |
| 33 | mbl-associated | 3 |
| 34 | herpesvirus-associated | 1 |
| 35 | cyclosis-mediated | 1 |
| 36 | treatment-mediated | 4 |
| 37 | art-mediated | 2 |
| 38 | trauma-potentiated | 5 |
| 39 | emotion-potentiated | 8 |
| 40 | fear-potentiated | 18 |
| 41 | anxiety-potentiated | 4 |
| 42 | elastase-related | 1 |
| 43 | cortisol-related | 2 |
| 44 | stimulation-related | 4 |
| 45 | ventilatory-related | 1 |
| 46 | boltzmann-weighted | 1 |
| 47 | hydrazine/hydroxylamine-assisted | 2 |
| 48 | water-assisted | 7 |
| 49 | ph-metry-adjusted | 1 |
| 50 | transthylakoid | 1 |
| 51 | 2.07-fold | 1 |
| 52 | legumain-like | 2 |
| 53 | s-nitrosocysteine | 1 |
| 54 | deprotection/thiol-acrylate | 1 |
| 55 | minor-to-moderate | 1 |
| 56 | pseudo-steady-state | 4 |
| 57 | immunofixation-negative | 1 |
| 58 | reversaling | 1 |
| 59 | nonhabituating | 1 |
| 60 | 2.3-log | 2 |
| 61 | 87.5-log | 1 |
| 62 | 4.8-log | 1 |
| 63 | 3.38-log | 1 |
| 64 | jendeki | 3 |
| 65 | eye-blink | 6 |
| 66 | global/clinical | 10 |
| 67 | 9-mg/dl | 1 |
| 68 | phosphotidyl | 1 |
| 69 | aza-peptidyl | 1 |
| 70 | 10-12rm | 1 |
| 71 | virus/serum | 1 |
| 72 | trans-septum | 3 |
| 73 | stimulus-driven | 15 |
| 74 | activity/protein | 1 |
| 75 | microcon | 1 |
| 76 | post-transition | 4 |
| 77 | proteasome-glo | 1 |
| 78 | g-imino | 1 |
| 79 | ≥3-step | 3 |
| 80 | trypsin-nor | 1 |
| 81 | absence-seizures | 1 |
| 82 | mass-screenings | 1 |
| 83 | micro-metastasis | 3 |
| 84 | nonsynchronous | 2 |
| 85 | tricostatus | 1 |
| 86 | hypoxia-dependent | 4 |
| 87 | non-concentration-dependent | 1 |
| 88 | 1.5-mev | 1 |
| 89 | rotaflow | 5 |
| 90 | cvw | 9 |
| 91 | thirsty-six | 1 |
| 92 | longer-latency | 2 |